Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation

Tissue Engineering - Part A

Volumn 16, Issue 1, 2010, Pages 153-164

  Volkmer, Elias ^a   Kallukalam, Bobby Cherian ^a   Maertz, Josef ^a   Otto, Sven ^b   Drosse, Inga ^a   Polzer, Hans ^a   Bocker, Wolfgang ^a   Stengele, Michael ^a   Docheva, Denitsa ^a   Mutschler, Wolf ^a   Schieker, Matthias ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELL CULTURE; OSTEOBLASTS; OXYGEN; TISSUE CULTURE;

BONE FORMATION; CELL SURVIVAL; CONSTANT LEVEL; DATA SUPPORT; DIFFERENTIATION PROCESS; ENGRAFTMENT; HUMAN MESENCHYMAL STEM CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); HYPOXIC CONDITION; IN-VITRO; IN-VIVO; LOW OXYGEN; MICROENVIRONMENTS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC POTENTIAL; OXYGEN ATMOSPHERE; PRE-TREATMENT; PRECURSOR CELLS; STEM-CELL NICHES; THREE-DIMENSIONAL SCAFFOLDS; VASCULARIZATION;

STEM CELLS;

ADULT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE; CYTOLOGY; FEMALE; FRACTURE; HUMAN; ISCHEMIC PRECONDITIONING; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM;

ADULT; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE, TRANSFORMED; FEMALE; FRACTURES, BONE; HUMANS; ISCHEMIC PRECONDITIONING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOGENESIS;

EID: 77049122836     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0021     Document Type: Article

References (47)

1. Schieker, M., and Mutschler, W. [Bridging posttraumatic bony defects. Established and new methods]. Unfallchirurg 109, 715, 2006.
2. Schieker, M., Heiss, C., and Mutschler, W. [Bone substitutes.]. Unfallchirurg 111, 613, 2008.
3. Drosse, I., Volkmer, E., Capanna, R., De Biase, P., Mutschler, W., and Schieker, M. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury 39 (Suppl 2), S9, 2008.
4. Braddock, M., Houston, P., Campbell, C., and Ashcroft, P. Born again bone: tissue engineering for bone repair. News Physiol Sci 16, 208, 2001.
5. Vacanti, C.A. History of tissue engineering and a glimpse into its future. Tissue Eng 12, 1137, 2006.
6. Malda, J., Klein, T.J., and Upton, Z. The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng 13, 2153, 2007.
7. Volkmer, E., Drosse, I., Otto, S., Stangelmayer, A., Stengele, M., Kallukalam, B.C., Mutschler, W., and Schieker, M. Hy-poxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng Part A 14, 1331, 2008.
8. Polykandriotis, E., Arkudas, A., Euler, S., Beier, J.P., Horch, R.E., and Kneser, U. [Prevascularisation strategies in tissue engineering]. Handchir Mikrochir Plast Chir 38, 217, 2006.
9. Giannoudis, P.V., Einhorn, T.A., and Marsh, D. Fracture healing: the diamond concept. Injury 38 (Suppl 4), S3, 2007.
10. Ke, Q., and Costa, M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70, 1469, 2006.
11. 2 homeostasis. Curr Opin Genet Dev 8, 588, 1998.
12. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15, 551, 1999.
13. Wang, Y., Wan, C., Deng, L., Liu, X., Cao, X., Gilbert, S.R., Bouxsein, M.L., Faugere, M.C., Guldberg, R.E., Gerstenfeld, L.C., Haase, V.H., Johnson, R.S., Schipani, E., and Clemens, T.L. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117, 1616, 2007.
14. Hitchon, C.A., and El Gabalawy, H.S. Oxidation in rheumatoid arthritis. Arthritis Res Ther 6, 265, 2004.
15. Salim, A., Nacamuli, R.P., Morgan, E.F., Giaccia, A.J., and Longaker, M.T. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteo-blasts. J Biol Chem 279, 40007, 2004.
16. Potier, E., Ferreira, E., Andriamanalijaona, R., Pujol, J.P., Oudina, K., Logeart-Avramoglou, D., and Petite, H. Hypoxia affects mesenchymal stromal cell osteogenic dif-ferentiation and angiogenic factor expression. Bone 40, 1078, 2007.
17. Park, J.H., Park, B.H., Kim, H.K., Park, T.S., and Baek, H.S. Hypoxia decreases Runx2=Cbfa1 expression in human osteoblast-like cells. Mol Cell Endocrinol 192, 197, 2002.
18. Malladi, P., Xu, Y., Chiou, M., Giaccia, A.J., and Longaker, M.T. Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Am J Physiol Cell Physiol 290, C1139, 2006.
19. Grayson, W.L., Zhao, F., Izadpanah, R., Bunnell, B., and Ma, T. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 207, 331, 2006.
20. Grayson, W.L., Zhao, F., Bunnell, B., and Ma, T. Hypoxia enhances proliferation and tissue formation of human mes-enchymal stem cells. Biochem Biophys Res Commun 358, 948, 2007.
21. Fehrer, C., Brunauer, R., Laschober, G., Unterluggauer, H., Reitinger, S., Kloss, F., Gully, C., Gassner, R., and Lepper-dinger, G. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6, 745, 2007.
22. Utting, J.C., Robins, S.P., Brandao-Burch, A., Orriss, I.R., Behar, J., and Arnett, T.R. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res 312, 1693, 2006.
23. Warren, S.M., Steinbrech, D.S., Mehrara, B.J., Saadeh, P.B., Greenwald, J.A., Spector, J.A., Bouletreau, P.J., and Long-aker, M.T. Hypoxia regulates osteoblast gene expression. J Surg Res 99, 147, 2001.
24. Lennon, D.P., Edmison, J.M., and Caplan, A.I. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochon-drogenesis. J Cell Physiol 187, 345, 2001.
25. Lewis, J.S., Lee, J.A., Underwood, J.C., Harris, A.L., and Lewis, C.E. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66, 889, 1999.
26. Carrancio, S., Lopez-Holgado, N., Sanchez-Guijo, F.M., Vil-laron, E., Barbado, V., Tabera, S., Diez-Campelo, M., Blanco, J., San Miguel, J.F., and Del Canizo, M.C. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 36, 1014, 2008.
27. Rosova, I., Dao, M., Capoccia, B., Link, D., and Nolta, J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26, 2173, 2008.
28. Wang, J.A., Chen, T.L., Jiang, J., Shi, H., Gui, C., Luo, R.H., Xie, X.J., Xiang, M.X., and Zhang, X. Hypoxic preconditioning attenuates hypoxia=reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin 29, 74, 2008.
29. Wan, C., Gilbert, S.R., Wang, Y., Cao, X., Shen, X., Rama-swamy, G., Jacobsen, K.A., Alaql, Z.S., Eberhardt, A.W., Gerstenfeld, L.C., Einhorn, T.A., Deng, L., and Clemens, T.L. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 105, 686, 2008.
30. Bocker, W., Yin, Z., Drosse, I., Haasters, F., Rossmann, O., Wierer, M., Popov, C., Locher, M., Mutschler, W., Docheva, D., and Schieker, M. Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med 12, 1347, 2008.
31. Seitz, S., Ern, K., Lamper, G., Docheva, D., Drosse, I., Milz, S., Mutschler, W., and Schieker, M. Influence of in vitro cultivation on the integration of cell-matrix constructs after subcutaneous implantation. Tissue Eng 13, 1059, 2007.
32. Mylotte, L.A., Duffy, A.M., Murphy, M., O'Brien, T., Samali, A., Barry, F., and Szegezdi, E. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 26, 1325, 2008.
33. Ren, H., Cao, Y., Zhao, Q., Li, J., Zhou, C., Liao, L., Jia, M., Zhao, Q., Cai, H., Han, Z.C., Yang, R., Chen, G., and Zhao, R.C. Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Com-mun 347, 12, 2006.
34. Zhao, T., Zhang, C.P., Liu, Z.H., Wu, L.Y., Huang, X., Wu, H.T., Xiong, L., Wang, X., Wang, X.M., Zhu, L.L., and Fan, M. Hypoxia-driven proliferation of embryonic neural stem= progenitor cells-role of hypoxia-inducible transcription factor-1alpha. FEBS J 275, 1824, 2008.
35. 2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 102, 4783, 2005.
36. Hung, S.C., Pochampally, R.R., Hsu, S.C., Sanchez, C., Chen, S.C., Spees, J., and Prockop, D.J. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One 2, e416, 2007.
37. Ontiveros, C., Irwin, R., Wiseman, R.W., and McCabe, L.R. Hypoxia suppresses runx2 independent of modeled micro-gravity. J Cell Physiol 200, 169, 2004.
38. D'Ippolito, G., Diabira, S., Howard, G.A., Roos, B.A., and Schiller, P.C. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 39, 513, 2006.
39. Sodhi, C.P., Phadke, S.A., Batlle, D., and Sahai, A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50, 1482, 2001.
40. Gross, T.S., King, K.A., Rabaia, N.A., Pathare, P., and Sriniva-san, S. Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen. J Bone Miner Res 20, 250, 2005.
41. Hampel, D.J., Sansome, C., Romanov, V.I., Kowalski, A.J., Denhardt, D.T., and Goligorsky, M.S. Osteopontin traffic in hypoxic renal epithelial cells. Nephron Exp Nephrol 94, e66, 2003.
42. Potier, E., Ferreira, E., Meunier, A., Sedel, L., Logeart-Avramoglou, D., and Petite, H. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 13, 1325, 2007.
43. Sodek, J., Ganss, B., and McKee, M.D. Osteopontin. Crit Rev Oral Biol Med 11, 279, 2000.
44. Denhardt, D.T., Noda, M., O'Regan, A.W., Pavlin, D., and Berman, J.S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107, 1055, 2001.
45. Hu, X., Yu, S.P., Fraser, J.L., Lu, Z., Ogle, M.E., Wang, J.A., and Wei, L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135, 799, 2008.
46. Fink, T., Abildtrup, L., Fogd, K., Abdallah, B.M., Kassem, M., Ebbesen, P., and Zachar, V. Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia. Stem Cells 22, 1346, 2004.
47. Parmar, K., Mauch, P., Vergilio, J.A., Sackstein, R., and Down, J.D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 104, 5431, 2007.